Promising development in cancer treatment

A new method developed by the Swiss pharmaceutical company Novartis has been reported to be a significant step forward in cancer treatments. According to the Financial Times, Novartis's radioligand treatment, developed as an alternative to current radiotherapy, completely eliminated cancer that had spread throughout the body in just six months in some patients during clinical trials. Radiotherapy kills cancer cells with externally administered radiation, but this treatment method also damages healthy tissue. Radioligand therapy, however, is administered intravenously, allowing the radiation to be directed only at target cells.